AL
JAZZ icon

Airain Ltd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Airain Ltd’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,667
Closed -$1.42M – 752
2016
Q3 		$1.42M Sell
11,667
-41,464
-78% -$5.59M 0.08% 275
2016
Q2 		$7.51M Buy
+53,131
New +$7.83M 0.43% 62
2015
Q4 		– Sell
-50,342
Closed -$6.69M – 943
2015
Q3 		$6.69M Buy
50,342
+21,329
+74% +$3.67M 0.4% 76
2015
Q2 		$5.11M Buy
+29,013
New +$5.21M 0.29% 105
2014
Q3 		– Sell
-17,280
Closed -$2.54M – 876
2014
Q2 		$2.54M Buy
17,280
+1,533
+10% +$213K 0.21% 123
2014
Q1 		$2.18M Buy
+15,747
New +$2.37M 0.38% 58

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Airain Ltd's JAZZ Position: Q4 2016 in Review

Airain Ltd sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2016, closing a stake of 11,667 shares — an estimated $1.42M sold.

Airain Ltd first reported a position in JAZZ in Q1 2014 and held it in 6 quarters. The position peaked at $7.51M in Q2 2016. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

  • Airain Ltd reported no remaining Jazz Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Airain Ltd sold 11,667 Jazz Pharmaceuticals shares in Q4 2016, an estimated $1.42M.
  • Airain Ltd first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Airain Ltd's Jazz Pharmaceuticals position peaked at $7.51M in Q2 2016.
  • 295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on Airain Ltd's 13F filing for Q4 2016, filed 10 Feb 2017.